Evidence map›Paper›PMID 22131268›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2012

Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damage.

Benjamin Yuen, Simona Boncompagni, Wei Feng, Tianzhong Yang, Jose R Lopez, Klaus I Matthaei, Samuel R Goth, Feliciano Protasi, Clara Franzini-Armstrong, Paul D Allen and 1 more

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. RyR1-mediated CaProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Advances in malignant hyperthermia: novel insights into heat-induced CaJournal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Gene×environment interactions in autism spectrum disorders.Current topics in developmental biology · 2023
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Unravelling the unseen metabolic changes in patients with malignant hyperthermia.Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Benjamin YuenDepartment of Veterinary Molecular Biosciences, University of California, Davis, California, USA.
Simona Boncompagni
Wei Feng
Tianzhong Yang
Jose R Lopez
Klaus I Matthaei
Samuel R Goth
Feliciano Protasi
Clara Franzini-Armstrong
Paul D Allen
Isaac N Pessah
University of California, Davis · USBrigham and Women's Hospital · USInstitute on Aging · USAustralian National University · AUUniversity of Pennsylvania · US

Funding

Uncovering the Molecular Basis of Malignant HyperthermiaP01AR052354 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FRANZINI-ARMSTRONG, CLARA · 2006 to 2016
$13.4M
Molecular and Cellular Basis of PCB Developmental Neurotoxicity: ViCTER supplementR01ES014901 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HANS-JOACHIM LEHMLER, Pamela J Lein · 2009 to 2026
$9.3M
Structure Function Studies of RyR1 in a Myogenic KnockoutR01AR043140 · NIAMS · CHILDREN'S HOSPITAL BOSTON · PI ALLEN, PAUL D · 1996 to 2010
$4.8M
NIAMS NIH HHS 1P01 AR52354-05NIAMS NIH HHS 3R01 AR043140-15NIAMS NIH HHS P01 AR052354NIAMS NIH HHS R01 AR043140NIEHS NIH HHS 1R01 ES014901NIEHS NIH HHS R01 ES014901
6 · The paper itself

Abstract

Mutation T4825I in the type 1 ryanodine receptor (RYR1(T4825I/+)) confers human malignant hyperthermia susceptibility (MHS). We report a knock-in mouse line that expresses the isogenetic mutation T4826I. Heterozygous RYR1(T4826I/+) (Het) or homozygous RYR1(T4826I/T4826I) (Hom) mice are fully viable under typical rearing conditions but exhibit genotype- and sex-dependent susceptibility to environmental conditions that trigger MH. Hom mice maintain higher core temperatures than WT in the home cage, have chronically elevated myoplasmic[Ca(2+)](rest), and present muscle damage in soleus with a strong sex bias. Mice subjected to heat stress in an enclosed 37°C chamber fail to trigger MH regardless of genotype, whereas heat stress at 41°C invariably triggers fulminant MH in Hom, but not Het, mice within 20 min. WT and Het female mice fail to maintain euthermic body temperature when placed atop a bed whose surface is 37°C during halothane anesthesia (1.75%) and have no hyperthermic response, whereas 100% Hom mice of either sex and 17% of the Het males develop fulminant MH. WT mice placed on a 41°C bed maintain body temperature while being administered halothane, and 40% of the Het females and 100% of the Het males develop fulminant MH within 40 min. Myopathic alterations in soleus were apparent by 12 mo, including abnormally distributed and enlarged mitochondria, deeply infolded sarcolemma, and frequent Z-line streaming regions, which were more severe in males. These data demonstrate that an MHS mutation within the S4-S5 cytoplasmic linker of RYR1 confers genotype- and sex-dependent susceptibility to pharmacological and environmental stressors that trigger fulminant MH and promote myopathy.

Indexed as

MutationAmino Acid SubstitutionAnesthetics, InhalationAnimalsBody TemperatureFemaleGene ExpressionGenetic Predisposition to DiseaseGenotypeHalothaneHot TemperatureHumansMaleMalignant HyperthermiaMembrane PotentialsMiceAnesthetics, InhalationHalothaneRyanodine Receptor Calcium Release Channel

Identifiers

PMID22131268
PMCPMC3289506
OpenAlexW2012528202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.